Preparation and Evaluation of Diosmin-Loaded Diphenylcarbonate-Cross-Linked Cyclodextrin Nanosponges for Breast Cancer Therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preparation and Evaluation of Diosmin-Loaded Diphenylcarbonate-Cross-Linked Cyclodextrin Nanosponges for Breast Cancer Therapy
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 16, Issue 1, Pages 19
Publisher
MDPI AG
Online
2022-12-27
DOI
10.3390/ph16010019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abemaciclib-loaded ethylcellulose based nanosponges for sustained cytotoxicity against MCF-7 and MDA-MB-231 human breast cancer cells lines
- (2022) Md. Khalid Anwer et al. SAUDI PHARMACEUTICAL JOURNAL
- Potential and Therapeutic Roles of Diosmin in Human Diseases
- (2022) Etimad Huwait et al. Biomedicines
- Boosting the Anticancer Activity of Sunitinib Malate in Breast Cancer through Lipid Polymer Hybrid Nanoparticles Approach
- (2022) Mohammed Muqtader Ahmed et al. Polymers
- Enabling Oral Amphotericin B Delivery by Merging the Benefits of Prodrug Approach and Nanocarrier-Mediated Drug Delivery
- (2021) Kaushik Thanki et al. ACS Biomaterials-Science & Engineering
- Design of Olmesartan Medoxomil-Loaded Nanosponges for Hypertension and Lung Cancer Treatments
- (2021) Bjad K. Almutairy et al. Polymers
- Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment
- (2021) Md Abdus Subhan et al. Journal of Personalized Medicine
- Pharmacology of Diosmin, a Citrus Flavone Glycoside: An Updated Review
- (2021) Samar H. Gerges et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Development and Evaluation of Repurposed Etoricoxib Loaded Nanoemulsion for Improving Anticancer Activities against Lung Cancer Cells
- (2021) Shadab Md et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste
- (2020) Samia M. Omar et al. SAUDI PHARMACEUTICAL JOURNAL
- Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models
- (2020) Monica Argenziano et al. Cancers
- A Green RP-HPTLC-Densitometry Method for the Determination of Diosmin in Pharmaceutical Formulations
- (2020) Ahmed I. Foudah et al. Processes
- Preparation of spray dried amorphous solid dispersion of diosmin in soluplus with improved hepato-renoprotective activity: In vitro anti-oxidant and in-vivo safety studies
- (2020) Md Khalid Anwer et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cross-linked, cyclodextrin-based nanosponges for curcumin delivery - Physicochemical characterization, drug release, stability and cytotoxicity
- (2018) R. Pushpalatha et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Effectiveness and safety of a product containing diosmin, coumarin, and arbutin (Linfadren®) in addition to complex decongestive therapy on management of breast cancer-related lymphedema
- (2018) Angelo Cacchio et al. SUPPORTIVE CARE IN CANCER
- Diosmin-induced senescence, apoptosis and autophagy in breast cancer cells of different p53 status and ERK activity
- (2017) Anna Lewinska et al. TOXICOLOGY LETTERS
- Ordered and disordered cyclodextrin nanosponges with diverse physicochemical properties
- (2017) Vikramjeet Singh et al. RSC Advances
- Nanosponges: A Novel Class of Drug Delivery System - Review
- (2016) Selvamuthukumar S et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Measurement and correlation of solubility of diosmin in four pure solvents and β-cyclodextrin solution at 298.15K to 333.15K
- (2015) Md Khalid Anwer et al. CHINESE JOURNAL OF CHEMICAL ENGINEERING
- Diosmin downregulates the expression of T cell receptors, pro-inflammatory cytokines and NF-κB activation against LPS-induced acute lung injury in mice
- (2015) Faisal Imam et al. PHARMACOLOGICAL RESEARCH
- The application of nanosponges to cancer drug delivery
- (2014) Francesco Trotta et al. Expert Opinion on Drug Delivery
- Enhanced stability of a naringenin/2,6-dimethyl β-cyclodextrin inclusion complex: Molecular dynamics and free energy calculations based on MM- and QM-PBSA/GBSA
- (2014) Waratchada Sangpheak et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Water soluble binary and ternary complexes of diosmin with β-cyclodextrin: Spectroscopic characterization, release studies and anti-oxidant activity
- (2014) Md Khalid Anwer et al. JOURNAL OF MOLECULAR LIQUIDS
- Development of novel polymer-stabilized diosmin nanosuspensions: In vitro appraisal and ex vivo permeation
- (2013) May S. Freag et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Nanocarriers for Diagnosis and Targeting of Breast Cancer
- (2013) Arun Sharma et al. Biomed Research International
- Structural evidence of differential forms of nanosponges of beta-cyclodextrin and its effect on solubilization of a model drug
- (2012) Shankar Swaminathan et al. JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY
- Networking Properties of Cyclodextrin-Based Cross-Linked Polymers Probed by Inelastic Light-Scattering Experiments
- (2012) Barbara Rossi et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Cyclodextrin-based nanosponges: effective nanocarrier for Tamoxifen delivery
- (2012) Satyen Torne et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Cyclodextrin-Based Nanosponges for Delivery of Resveratrol: In Vitro Characterisation, Stability, Cytotoxicity and Permeation Study
- (2011) Khalid A. Ansari et al. AAPS PHARMSCITECH
- Expert opinion: Responsive polymer nanoparticles in cancer therapy
- (2011) William B. Liechty et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now